HCMT
SCLN

Highland Capital Management (Tennessee)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-270
Closed -$2K – 630
2015
Q3 		$2K Hold
270
– – ﹤0.01% 639
2015
Q2 		$3K Buy
+270
New +$2.46K ﹤0.01% 633

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Highland Capital Management (Tennessee)'s SCLN Position: Q4 2015 in Review

Highland Capital Management (Tennessee) sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2015, closing a stake of 270 shares — an estimated $2K sold.

Highland Capital Management (Tennessee) first reported a position in SCLN in Q2 2015 and held it in 2 quarters. The position peaked at $3K in Q2 2015. 133 funds tracked by Wall St. Rank hold SCLN as of Q4 2015.

  • Highland Capital Management (Tennessee) reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 270 Sciclone Pharmaceuticals Inc shares in Q4 2015, an estimated $2K.
  • Highland Capital Management (Tennessee) first reported a position in Sciclone Pharmaceuticals Inc in Q2 2015 and held it in 2 quarters.
  • Highland Capital Management (Tennessee)'s Sciclone Pharmaceuticals Inc position peaked at $3K in Q2 2015.
  • 133 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2015.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q4 2015, filed 27 Jan 2016.